Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 04 04:00PM ET
0.1418
Dollar change
+0.0025
Percentage change
1.79
%
Index- P/E- EPS (ttm)-22.15 Insider Own0.00% Shs Outstand137.26M Perf Week-20.78%
Market Cap18.66M Forward P/E- EPS next Y-14.23 Insider Trans- Shs Float137.26M Perf Month1.72%
Income-149.01M PEG- EPS next Q-3.88 Inst Own0.43% Short Float3.98% Perf Quarter-69.01%
Sales12.46M P/S1.50 EPS this Y31.99% Inst Trans85.28% Short Ratio0.18 Perf Half Y-97.72%
Book/sh4.28 P/B0.03 EPS next Y23.96% ROA-129.55% Short Interest5.46M Perf Year-99.11%
Cash/sh0.03 P/C4.49 EPS next 5Y- ROE-163.24% 52W Range0.12 - 22.14 Perf YTD-98.90%
Dividend Est.- P/FCF- EPS past 5Y79.31% ROI-308.74% 52W High-99.36% Beta2.15
Dividend TTM- Quick Ratio0.72 Sales past 5Y0.00% Gross Margin-17.61% 52W Low20.17% ATR (14)0.02
Dividend Ex-Date- Current Ratio1.15 EPS Y/Y TTM-61.43% Oper. Margin-764.06% RSI (14)39.46 Volatility12.42% 12.83%
Employees103 Debt/Eq0.22 Sales Y/Y TTM- Profit Margin-1196.11% Recom1.00 Target Price26.00
Option/ShortNo / No LT Debt/Eq0.15 EPS Q/Q-619.99% Payout- Rel Volume0.46 Prev Close0.14
Sales Surprise-36.91% EPS Surprise-489.01% Sales Q/Q- EarningsAug 19 BMO Avg Volume31.08M Price0.14
SMA20-10.68% SMA50-15.17% SMA200-96.61% Trades Volume14,422,584 Change1.79%
Date Action Analyst Rating Change Price Target Change
Apr-18-22Initiated Noble Capital Markets Outperform
Apr-18-19Upgrade ROTH Capital Neutral → Buy $4
Aug-18-17Upgrade ROTH Capital Neutral → Buy $6
Sep-07-16Downgrade ROTH Capital Buy → Neutral
Feb-17-16Reiterated Oppenheimer Outperform $18 → $10
Nov-04-15Initiated Cantor Fitzgerald Buy
Jun-12-15Initiated Oppenheimer Outperform $18
Feb-17-15Reiterated ROTH Capital Buy $10 → $12
Sep-29-14Reiterated ROTH Capital Buy $17 → $10
Today 07:00AM
Nov-01-24 07:00AM
Oct-29-24 08:00AM
Oct-25-24 08:00AM
Oct-24-24 08:00AM
08:00AM Loading…
Oct-17-24 08:00AM
Oct-16-24 01:01PM
08:00AM
Oct-09-24 07:28AM
Oct-08-24 08:30AM
Oct-01-24 01:31PM
07:30AM
Sep-30-24 07:00AM
Sep-27-24 07:00AM
Sep-23-24 07:00AM
07:00AM Loading…
Sep-19-24 07:00AM
Sep-18-24 07:30AM
Sep-16-24 07:00AM
Sep-11-24 01:00PM
Sep-10-24 07:00AM
Sep-09-24 07:00AM
Sep-06-24 07:00AM
Sep-04-24 07:00AM
Aug-29-24 07:00AM
Aug-28-24 07:00AM
Aug-26-24 10:41AM
07:00AM
Aug-23-24 07:45AM
Aug-21-24 07:00AM
Aug-20-24 12:34PM
07:00AM Loading…
07:00AM
Aug-19-24 06:00AM
Aug-16-24 10:52PM
01:29PM
07:00AM
Aug-13-24 08:00AM
Aug-12-24 08:00AM
Aug-06-24 08:00AM
Aug-01-24 07:45AM
Jul-31-24 08:00AM
Jul-30-24 08:00AM
Jul-29-24 09:00AM
Jul-25-24 08:30AM
08:00AM
Jul-24-24 07:45AM
Jul-22-24 07:00AM
Jul-19-24 12:48PM
Jul-18-24 10:20AM
Jul-17-24 08:00AM
Jul-10-24 04:30PM
Jul-09-24 09:15AM
07:39AM
Jul-08-24 05:00PM
08:00AM
07:00AM
Jul-01-24 11:07AM
08:00AM
Jun-28-24 04:05PM
Jun-27-24 11:01AM
08:37AM
08:36AM
07:34AM
Jun-26-24 04:40PM
03:13PM
Jun-25-24 08:00AM
Jun-21-24 07:30AM
Jun-20-24 08:00AM
Jun-18-24 12:31PM
08:00AM
Jun-17-24 08:00AM
Jun-13-24 05:00PM
Jun-12-24 10:06AM
09:00AM
08:52AM
07:46AM
Jun-11-24 05:17PM
10:26AM
Jun-10-24 12:14PM
11:55AM
Jun-06-24 11:00AM
08:00AM
Jun-05-24 08:00AM
Jun-03-24 08:00AM
May-30-24 08:00AM
May-29-24 08:00AM
May-28-24 08:00AM
May-22-24 08:00AM
May-21-24 08:00AM
May-20-24 10:53AM
May-15-24 08:00AM
May-13-24 04:30PM
Apr-29-24 09:00AM
Apr-24-24 08:00AM
Apr-09-24 06:31AM
Apr-01-24 04:15PM
Mar-28-24 09:32AM
Mar-25-24 08:00AM
Mar-24-24 04:05PM
Mar-21-24 08:00AM
Mar-20-24 08:00AM
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.